INS and metabolic dysfunction-associated steatotic liver disease: Thus, further studies are needed to investigate associations between those parameters and non-alcoholic fatty liver disease (NAFLD) markers to clarify whether NAFLD affects fasting insulin and UAE independent of glycemia, hypertension, and other confounders.